Impact of estrogen therapy on Alzheimer's disease: a fork in the road? (Q35771516)

10 August 2017

1 reference

title

Impact of estrogen therapy on Alzheimer's disease: a fork in the road? (English)

1 reference

10 August 2017

0 references

1 reference

Roberta D Brinton

1

1 reference

10 August 2017

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

18

1 reference

10 August 2017

7

1 reference

10 August 2017

405-422

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200418070-00001

10 August 2017

0 references

cites work

Increased risk of familial late-onset Alzheimer's disease in women.

1 reference

12 December 2020

Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators

1 reference

12 December 2020

The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective

1 reference

12 December 2020

Chemical andropause and amyloid-beta peptide.

1 reference

12 December 2020

"MENOPAUSAL SYMPTOMS" IN WOMEN OF VARIOUS AGES

1 reference

12 December 2020

Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease

1 reference

12 December 2020

Barriers to drug discovery and development for Alzheimer disease.

1 reference

12 December 2020

Therapeutic potential of selective estrogen receptor modulators

1 reference

12 December 2020

Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway

1 reference

12 December 2020

Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling

1 reference

12 December 2020

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

1 reference

12 December 2020

Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

1 reference

12 December 2020

Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury

1 reference

12 December 2020

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Women's concerns with hormone replacement therapy--compliance issues

1 reference

12 December 2020

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

1 reference

12 December 2020

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

12 December 2020

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

1 reference

12 December 2020

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

12 December 2020

Hormone replacement therapy and cognition: systematic review and meta-analysis

1 reference

12 December 2020

Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice.

1 reference

12 December 2020

The current status of intra-uterine contraceptive devices and systems.

1 reference

12 December 2020

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

12 December 2020

Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression

1 reference

12 December 2020

Novel delivery systems in contraception

1 reference

12 December 2020

Estrogen and cognitive aging in women

1 reference

12 December 2020

Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges

1 reference

12 December 2020

Estrogen to treat Alzheimer's disease: too little, too late? So what's a woman to do?

1 reference

12 December 2020

Hormone therapy and risk of Alzheimer disease: a critical time.

1 reference

12 December 2020

The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis.

1 reference

12 December 2020

Memory retention is modulated by acute estradiol and progesterone replacement

1 reference

12 December 2020

Modulation of A(beta) peptides by estrogen in mouse models

1 reference

12 December 2020

Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat.

1 reference

12 December 2020

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

12 December 2020

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

1 reference

12 December 2020

Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.

1 reference

12 December 2020

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

1 reference

12 December 2020

Advances in contraception

1 reference

12 December 2020

1 reference

12 December 2020

Different modes of hippocampal plasticity in response to estrogen in young and aged female rats

1 reference

12 December 2020

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

1 reference

12 December 2020

Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy

1 reference

12 December 2020

Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women

1 reference

12 December 2020

Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism

1 reference

12 December 2020

Impact of progestins on estradiol potentiation of the glutamate calcium response

1 reference

12 December 2020

Combined oral hormone replacement therapy formulations

1 reference

12 December 2020

Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate

1 reference

12 December 2020

Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease

1 reference

12 December 2020

Oestrogen and cognitive function throughout the female lifespan

1 reference

12 December 2020

The role of estrogen in the treatment of Alzheimer's disease

1 reference

12 December 2020

Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?

1 reference

12 December 2020

New populations of old add to poor nations' burdens

1 reference

12 December 2020

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

12 December 2020

Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway

1 reference

12 December 2020

Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione

1 reference

12 December 2020

Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain

1 reference

12 December 2020

Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex

1 reference

12 December 2020

Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons

1 reference

12 December 2020

Ovarian steroids and the brain: implications for cognition and aging

1 reference

12 December 2020

A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health.

1 reference

12 December 2020

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

1 reference

12 December 2020

Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus.

1 reference

12 December 2020

Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice

1 reference

12 December 2020

Neuropathology of preclinical and clinical late-onset Alzheimer's disease.

1 reference

12 December 2020

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

12 December 2020

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys

1 reference

12 December 2020

Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type.

1 reference

12 December 2020

Calcium dysregulation in neuronal aging and Alzheimer's disease: history and new directions

1 reference

12 December 2020

Hormone therapy and the brain: déjà vu all over again?

1 reference

12 December 2020

The Women’s Health Initiative Memory Study (WHIMS)

1 reference

12 December 2020

10.2165/00023210-200418070-00001

Identifiers

DOI

1 reference

PubMed ID

15139797

Dimensions Publication ID

10 August 2017

0 references

1 reference

PubMed ID

15139797